Reported Resistance Case(s)

Species: aedes aegypti

Order	Family	Common Name(s)	Group	Host
diptera	culicidae	yellow fever mosquito	MED	human

Active Ingredient: acetamiprid

MOA: Nicotinic Acetylcholine receptor agonists / antagonists, Neonicotinoids
Group: NICO	CAS #: 135410-20-7	Shaugnessy Code: 99050

Resistance Case(s)

Case Id	Year of Report	Type of Resistance	Location	Reference
G21603	2022	Lab selected*	India-- New Delh	Samal, R. R., Panmei, K., Lanbiliu, P., and Kumar, S. (2022). Reversion of CYP450 monooxygenase-mediated acetamiprid larval resistance in dengue fever mosquito, Aedes aegypti L.. Reversion of CYP450 monooxygenase-mediated acetamiprid larval resistance in dengue fever mosquito, Aedes aegypti L. 1-10.
G21604	2022	Lab selected*	India-- New Delh	Samal, R. R., Panmei, K., Lanbiliu, P., and Kumar, S. (2022). Reversion of CYP450 monooxygenase-mediated acetamiprid larval resistance in dengue fever mosquito, Aedes aegypti L.. Reversion of CYP450 monooxygenase-mediated acetamiprid larval resistance in dengue fever mosquito, Aedes aegypti L. 1-10.
G22834	2022	Lab selected after field-evolved resistance**	India-- Govindpuri-- Delhi	Samal, R. R., Panmei, K., Lanbiliu, P., & Kumar, S. (2022). Reversion of CYP450 monooxygenase-mediated acetamiprid larval resistance in dengue fever mosquito, Aedes aegypti L.. Bulletin of entomological research, 112.
G22835	2022	Lab selected after field-evolved resistance**	India-- Govindpuri-- Delhi	Samal, R. R., Panmei, K., Lanbiliu, P., & Kumar, S. (2022). Reversion of CYP450 monooxygenase-mediated acetamiprid larval resistance in dengue fever mosquito, Aedes aegypti L.. Bulletin of entomological research, 112.

*The population was created solely by selection and/or genetic manipulation.
**The population was selected further in the laboratory after collection.